WSB1 as a Maker for Metastasis and Therapeutic Target for the HIF Pathway

Technology #2015-164

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Categories
Researchers
Zhenkun Lou Ph.D.
Managed By
Leif R. Nelson
Patent Protection
US Patent Pending

Mayo Clinic has discovered that WSB1 can be used as a diagnostic marker for tumor metastasis and a therapeutic target.